Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJPMorgan American Regulatory News (JAM)

Share Price Information for JPMorgan American (JAM)

Share Price is delayed by 15 minutes
Get Live Data
1,212.00    6.00 (0.50%)
Bid:
1,210.00
Ask:
1,214.00
Spread: 4.00 (0.331%)
Market Cap: £2.01b
JAM Live PriceLast checked at - London Stock Exchange

Intraday JPMorgan American Share Chart

Closed Period Notification

2 Jan 2026 14:49

RNS Number : 5260N
JPMorgan American IT PLC
02 January 2026
 

JPMORGAN AMERICAN INVESTMENT TRUST PLC

(the 'Company')

 

Compliance with Market Abuse Regulation

 

Closed Period Notification

 

Legal Entity Identifier: 549300QNAI4XRPEB4G65

Information disclosed in accordance with UK Market Abuse Regulation

 

The Company announces that it is satisfied that all inside information which the Directors and the Company may have in the period leading up to the announcement of its results for the year ended 31st December 2025 has previously been, and will continue to be, notified to the London Stock Exchange ('LSE') via a regulatory information service. Therefore, the Company is not prohibited from dealing in its own securities.

 

The mandatory closed period under Market Abuse Regulation will commence on 17th February 2026 and will last until the results in respect of the year ended 31st December 2025 are published on or around 1st April 2026.

 

If in the period leading up to the announcement of the year end results, the Directors of the Company come into the possession of any inside information, this will be notified to the LSE before any such transactions are undertaken.

 

 

2nd January 2026

 

 

For further information, please contact:

 

Divya Amin

 

JPMorgan Funds Limited - Company Secretary

Telephone 0800 20 40 20 (or +44 1268 44 44 70)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBSGDBISGDGLD
Date   Source Headline
22nd Aug 202511:26 amRNSNet Asset Value(s)
21st Aug 20255:09 pmRNSTransaction in Own Shares
21st Aug 202511:06 amRNSNet Asset Value(s)
21st Aug 20257:00 amRNS-RKepler Trust Intelligence: New Research
20th Aug 20255:05 pmRNSTransaction in Own Shares
20th Aug 202511:01 amRNSNet Asset Value(s)
19th Aug 20255:08 pmRNSTransaction in Own Shares
19th Aug 202510:36 amRNSNet Asset Value(s)
18th Aug 20255:03 pmRNSTransaction in Own Shares
18th Aug 20253:05 pmRNSGearing Announcement
18th Aug 202511:13 amRNSNet Asset Value(s)
15th Aug 20255:21 pmRNSTransaction in Own Shares
15th Aug 202511:09 amRNSNet Asset Value(s)
14th Aug 20255:16 pmRNSTransaction in Own Shares
14th Aug 202510:49 amRNSNet Asset Value(s)
14th Aug 20257:05 amRNSDividend Declaration
14th Aug 20257:00 amRNSHalf-year Report
13th Aug 20255:17 pmRNSTransaction in Own Shares
13th Aug 202510:50 amRNSNet Asset Value(s)
12th Aug 20255:16 pmRNSTransaction in Own Shares
12th Aug 20254:34 pmRNSTen Largest Investments
12th Aug 20253:24 pmRNSHolding(s) in Company
12th Aug 202511:45 amRNSNet Asset Value(s)
11th Aug 20255:13 pmRNSTransaction in Own Shares
11th Aug 202512:56 pmRNSGearing announcement
11th Aug 202512:13 pmRNSNet Asset Value(s)
8th Aug 20255:00 pmRNSTransaction in Own Shares
8th Aug 202510:52 amRNSNet Asset Value(s)
7th Aug 20255:19 pmRNSTransaction in Own Shares
7th Aug 202510:53 amRNSNet Asset Value(s)
6th Aug 20255:16 pmRNSTransaction in Own Shares
6th Aug 202511:04 amRNSNet Asset Value(s)
5th Aug 20255:10 pmRNSTransaction in Own Shares
5th Aug 202511:26 amRNSNet Asset Value(s)
4th Aug 20255:11 pmRNSTransaction in Own Shares
4th Aug 202511:24 amRNSGearing announcement
4th Aug 202511:04 amRNSNet Asset Value(s)
1st Aug 202511:23 amRNSNet Asset Value(s)
1st Aug 202510:05 amRNSTotal Voting Rights
31st Jul 20255:10 pmRNSTransaction in Own Shares
31st Jul 202510:45 amRNSNet Asset Value(s)
30th Jul 20255:55 pmRNSTransaction in Own Shares
30th Jul 202510:35 amRNSNet Asset Value(s)
29th Jul 20255:13 pmRNSTransaction in Own Shares
29th Jul 202510:40 amRNSNet Asset Value(s)
28th Jul 20255:08 pmRNSTransaction in Own Shares
28th Jul 202511:10 amRNSGearing Announcement
28th Jul 202510:34 amRNSNet Asset Value(s)
25th Jul 20255:03 pmRNSTransaction in Own Shares
25th Jul 202511:10 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.